Cancer, Nos
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Maladaptive Adipose Tissue Activity in Cancer (NCT03621124) | Virginia Commonwealth University | 2018-08-16 |
| Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor (NCT01750580) | Bristol-Myers Squibb | 2012-12-01 |
| A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors (NCT01714739) | Bristol-Myers Squibb | 2012-10-07 |
| Analysis of Neurocognitive Elements of Attention After Chemotherapy (NCT03052868) | University of Texas Southwestern Medical Center | 2011-07-01 |
Track Cancer, Nos automatically
Every clearance here is in the API, with alerts when new ones post.